About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 912413, 9 pages
http://dx.doi.org/10.1155/2013/912413
Research Article

Factors Affecting Graft Survival among Patients Receiving Kidneys from Live Donors: A Single-Center Experience

1Department of Urology , The Urology & Nephrology Center, Mansoura, Egypt
2Division of Nephrology, The Urology & Nephrology Center, Mansoura, Egypt
3Division of Immunology , The Urology & Nephrology Center, Mansoura, Egypt
4Division of Pathology, The Urology & Nephrology Center, Mansoura, Egypt

Received 27 April 2013; Revised 11 June 2013; Accepted 11 June 2013

Academic Editor: Gerald Brandacher

Copyright © 2013 Mohamed A. Ghoneim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. A. Ghoneim, M. A. Sobh, A. A. Shokeir, et al., “Prospective randomized study of azathioprine versus cyclosporin in live-donor kidney transplantation,” American Journal of Nephrology, vol. 13, no. 6, pp. 437–441, 1993. View at Scopus
  2. M. A. Ghoneim, M. A. Sobh, A. A. Shokeir, M. A. Bakr, A. El-Sherif, and M. A. Foda, “Prospective randomized study of triple Vs conventional immunosuppression in living-donor kidney transplantation,” Transplantation Proceedings, vol. 25, no. 3, pp. 2243–2245, 1993. View at Scopus
  3. A. H. Nematalla, M. A. Bakr, O. A. Gheith, et al., “Steroid-avoidance immunosuppression regimen in live-donor renal allotransplant recipients: a prospective, randomized controlled study,” Experimental and Clinical Transplantation, vol. 5, no. 2, pp. 673–679, 2007. View at Scopus
  4. A. F. Hamdy, M. A. Bakr, and M. A. Ghoneim, “Long-term efficacy and safety of a calcineurin inhibitor-free regimen in live-donor renal transplant recipients,” Journal of the American Society of Nephrology, vol. 19, no. 6, pp. 1225–1232, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. J. E. Tuttle-Newhall, S. M. Krishnan, M. F. Levy, et al., “Organ donation and utilization in the United States: 1998–2007,” American Journal of Transplantation, vol. 9, no. 4, part 2, pp. 879–893, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. DSO report on organ donation and transplantation in Germany 2000, pp. 45-46.
  7. S. Lee, J. Kim, M. Shin et al., “Comparison of outcomes of living and deceased donor kidney grafts surviving longer than 5 years in Korea,” Transplantation Proceedings, vol. 42, no. 3, pp. 775–777, 2010. View at Scopus
  8. J. I. Roodnat, I. C. van Riemsdijk, P. G. H. Mulder et al., “The superior results of living-donor renal transplantation are not completely caused by selection or short cold ischemia time: a single-center, multivariate analysis,” Transplantation, vol. 75, no. 12, pp. 2014–2018, 2003. View at Scopus
  9. S. V. Fuggle, J. E. Allen, R. J. Johnson et al., “Factors affecting graft and patient survival after live donor kidney transplantation in the UK,” Transplantation, vol. 89, no. 6, pp. 694–701, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. J. A. Lowell, D. C. Brennan, S. Shenoy et al., “Living-unrelated renal transplantation provides comparable results to living-related renal transplantation: a 12-year single-center experience,” Surgery, vol. 119, no. 5, pp. 538–543, 1996. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Futagawa, K. Waki, D. W. Gjertson, and P. I. Terasaki, “Living-unrelated donors yield higher graft survival rates than parental donors,” Transplantation, vol. 79, no. 9, pp. 1169–1174, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. M. El-Mekresh, Y. Osman, B. Ali-El-Dein, T. El-Diasty, and M. A. Ghoneim, “Urological complications after living-donor renal transplantation,” BJU International, vol. 87, no. 4, pp. 295–306, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. N. Issa, B. Stephany, R. Fatica et al., “Donor factors influencing graft outcomes in live donor kidney transplantation,” Transplantation, vol. 83, no. 5, pp. 593–599, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Noppakun, F. G. Cosio, P. G. Dean, S. J. Taler, R. Wauters, and J. P. Grande, “Living donor age and kidney transplant outcomes,” American Journal of Transplantation, vol. 11, no. 6, pp. 1279–1286, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. L. S. Peña De La Vega, A. Torres, H. E. Bohorquez et al., “Patient and graft outcomes from older living kidney donors are similar to those from younger donors despite lower GFR,” Kidney International, vol. 66, no. 4, pp. 1654–1661, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. M. A. Ghoneim, M. A. Bakr, N. Hassan et al., “Live-donor renal transplantation at the Urology & Nephrology Center of Mansoura: 1976–1998,” Clinical Transplants, pp. 167–178, 2001. View at Scopus
  17. Collaborative Transplant Study, University of Heidelberg, Germany, January 2012, http://www.ctstransplant.org.
  18. R. Weimer, S. Deisz, H. Dietrich et al., “Impact of maintenance immunosuppressive regimens-balance between graft protective suppression of immune functions and a near physiological immune response,” Transplant International, vol. 24, no. 6, pp. 596–609, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Nashan, R. Moore, P. Amlot, A. G. Schmidt, K. Abeywickrama, and J. P. Soulillou, “Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients,” The Lancet, vol. 350, no. 9086, pp. 1193–1198, 1997. View at Scopus
  20. P. A. Keown, R. Balshaw, S. Khorasheh et al., “Meta-analysis of basiliximab for immunoprophylaxis in renal transplantation,” BioDrugs, vol. 17, no. 4, pp. 271–279, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. H. A. Sheashaa, M. A. Bakr, R. H. Rashad, A. M. Ismail, M. A. Sobh, and M. A. Ghoneim, “Ten-year follow-up of basiliximab induction therapy for live-donor kidney transplant: a prospective randomized controlled study,” Experimental and Clinical Transplantation, vol. 9, no. 4, pp. 247–251, 2011. View at Scopus
  22. I. Lemieux, I. Houde, A. Pascot et al., “Effects of prednisone withdrawal on the new metabolic triad in cyclosporine-treated kidney transplant patients,” Kidney International, vol. 62, no. 5, pp. 1839–1847, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Opelz, B. Döhler, G. Laux, and Collaborative Transplant Study, “Long-term prospective study of steroid withdrawal in kidney and heart transplant recipients,” American Journal of Transplantation, vol. 5, no. 4 I, pp. 720–728, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. E. S. Woodle, M. R. First, J. Pirsch et al., “A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy,” Annals of Surgery, vol. 248, no. 4, pp. 564–577, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Lightner, W. Concepcion, and P. Grimm, “Steroid avoidance in renal transplantation,” Current Opinion in Organ Transplantation, vol. 16, no. 5, pp. 477–482, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Pascual, “Steroid avoidance or withdrawal in kidney transplantation,” Current Opinion in Organ Transplantation, vol. 16, no. 6, pp. 600–605, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. S. R. Knight and P. J. Morris, “Steroid avoidance or withdrawal after renal transplantation increases the risk of acute rejection but decreases cardiovascular risk. A meta-analysis,” Transplantation, vol. 89, no. 1, pp. 1–14, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. G. Remuzzi and N. Perico, “Cyclosporine-induced renal dysfunction in experimental animals and humans,” Kidney International, vol. 52, pp. S70–S74, 1995. View at Scopus
  29. B. D. Myers and L. Newton, “Cyclosporine-induced chronic nephropathy: an obliterative microvascular renal injury,” Journal of the American Society of Nephrology, vol. 2, supplement 1, pp. S45–S52, 1991. View at Scopus
  30. B. J. Nankivell, R. J. Borrows, C. L. Fung, P. J. O'Connell, R. D. M. Allen, and J. R. Chapman, “The natural history of chronic allograft nephropathy,” The New England Journal of Medicine, vol. 349, no. 24, pp. 2326–2333, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. A. F. Refaie, K. M. Mahmoud, A. M. Ismail, H. A. Sheashaa, A. I. Kamal, and M. A. Ghoneim, “Alemtuzumab preconditioning allows steroid-calcineurin inhibitor-free regimen in live-donor kidney transplant,” Experimental and Clinical Transplantation, vol. 9, no. 5, pp. 295–301, 2011. View at Scopus
  32. A. F. Donia, A. Mostafa, H. Refaie, M. El-Baz, M. M. Kamal, and M. A. Ghoneim, “Postkidney transplant malignancy in Egypt has a unique pattern: a three-decade experience,” Transplantation, vol. 86, no. 8, pp. 1139–1142, 2008. View at Publisher · View at Google Scholar · View at Scopus